These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9648947)

  • 1. Chlorofluorocarbon-free inhalers: are we ready for the change?
    Partridge MR; Woodcock AA; Sheffer AL; Wanner A; Rubinfeld A
    Eur Respir J; 1998 May; 11(5):1006-8. PubMed ID: 9648947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition to CFC-free metered dose inhalers--into the new millennium.
    McDonald KJ; Martin GP
    Int J Pharm; 2000 May; 201(1):89-107. PubMed ID: 10867268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorofluorocarbon-free aerosol therapy in patients with pulmonary airflow obstruction.
    Matthys H
    Respiration; 1996; 63(6):321-4. PubMed ID: 8933648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ozone layer and metered dose inhalers.
    Boulet LP
    Can Respir J; 1998; 5(3):176-9. PubMed ID: 9707462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in metered dose inhaler propellants].
    Chinet T
    Rev Mal Respir; 2000 Feb; 17(1):15-20. PubMed ID: 10756552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance.
    Cummings RH
    J Allergy Clin Immunol; 1999 Dec; 104(6):S230-6. PubMed ID: 10588980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New delivery systems and propellants.
    Dolovich M
    Can Respir J; 1999; 6(3):290-5. PubMed ID: 10393290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A United States regulator's perspective on the ongoing chlorofluorocarbon transition.
    Meyer RJ
    J Allergy Clin Immunol; 1999 Dec; 104(6):S236-8. PubMed ID: 10588981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transition in practice: health professionals and patients.
    Partridge MR
    Br J Clin Pract Suppl; 1997 May; 89():32-6. PubMed ID: 9519511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The technical transition to CFC-free inhalers.
    Tansey I
    Br J Clin Pract Suppl; 1997 May; 89():22-7. PubMed ID: 9519509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of international environmental agreements in metered-dose inhaler technology changes.
    Forte R; Dibble C
    J Allergy Clin Immunol; 1999 Dec; 104(6):S217-20. PubMed ID: 10588977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorofluorocarbon to hydrofluoroalkane formulations: an industry perspective.
    Atkins P
    J Allergy Clin Immunol; 1999 Dec; 104(6):S268-70. PubMed ID: 10588988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CFCs, their replacements, and the ozone layer.
    Noakes TJ
    J Aerosol Med; 1995; 8 Suppl 1():S3-7. PubMed ID: 10150493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History of aerosol therapy: liquid nebulization to MDIs to DPIs.
    Anderson PJ
    Respir Care; 2005 Sep; 50(9):1139-50. PubMed ID: 16122398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moisture transport into chlorofluorocarbon-free metered dose inhalers.
    Williams G
    J Allergy Clin Immunol; 1999 Dec; 104(6):S227-9. PubMed ID: 10588979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of inhalant medications with and without chlorofluorocarbon propellants in the United States, 1996-2000.
    Wysowski DK; Swann J
    J Allergy Clin Immunol; 2002 Jul; 110(1):51-3. PubMed ID: 12110819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.